a day ago
Seeds of Innocencs showcases Home IVF as a tech-enabled model for expanding fertility care
New Delhi:
Dr. Gauri Agarwal
, Founder of Seeds of Innocens has highlighted the organisation's
Home IVF
platform as a technology-enabled approach to improving access to
fertility care
in India.
It is indicated that the platform is developed to address barriers such as stigma, distance, and limited local infrastructure, the at-home model allows couples to initiate and manage much of their fertility treatment without frequent clinic visits.
Home IVF integrates virtual consultations, customised treatment plans, home-based hormone injections, and diagnostic tracking with ongoing clinical oversight.
Additional services include
reproductive counselling
, remote monitoring, at-home semen analysis, and AI-enabled assistance through the Doctor IVF digital tool.
The platform also supports the use of ovulation trackers and self-insemination kits, offering professional guidance to ensure treatment quality outside traditional settings.
Dr. Agarwal noted that the model is aimed at expanding access beyond urban centres to underserved areas, particularly tier-2 and tier-3 cities, where logistical, financial, and social hurdles often delay or prevent treatment. By decentralising the fertility journey, Home IVF seeks to make assisted reproduction more adaptable and patient-focused.
'We have already seen the transformative impact of the Home IVF model in real-life cases. One woman from West Champaran, Bihar, conceived twins through the platform with minimal clinic visits.
This approach empowers patients who face mobility issues, social hesitation, or live far from fertility centres. Equally encouraging is how the model resonates with working couples in metro cities, international patients, and individuals opting for egg freezing or delayed parenthood.
There is growing demand for fertility care that is not only effective, but also private, flexible, and aligned with the needs of today's patients. Early-stage genetic testing—particularly for conditions like beta-thalassemia—is enabling couples to make informed reproductive choices and prevent the transmission of hereditary disorders,' said Dr. Gauri Agarwal.
